Cooley advised Reneo, and Latham & Watkins advised the underwriters and placement agents. Reneo Pharmaceuticals, Inc. announced the pricing of its previously announced underwritten public offering of...
You must be a Standard 1 Year member to access this content.
Meitar and Cooley advised Gamida Cell on the offering, and Davis Polk advised the underwriter. Gamida Cell Ltd. announced the $23 million SEC-registered follow-on offering of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised TELA Bio, while Latham & Watkins advised the underwriters on the offering. TELA Bio, Inc. has announced the pricing of its previously announced underwritten...
You must be a Standard 1 Year member to access this content.
Davis Polk is advising Xponential Fitness on the offering, and Latham & Watkins is advising the underwriters involved. Xponential Fitness, Inc. has announced the pricing of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers involved in the offering, while Gibson Dunn and Van Campen Liem advised Expro. The selling shareholders were assisted by...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Cactus Inc. on the stock offering and Simpson Thacher advised the underwriters involved. Cactus Inc. announced its $172.5 million follow-on offering of 3,224,300 shares of...
You must be a Standard 1 Year member to access this content.
DLA Piper advised Skyward Specialty, while Latham & Watkins LLP represented the underwriters in the offering. Skyward Specialty Insurance Group, Inc., a specialty insurance company, delivering...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised the underwriters on the deal. Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Tenaya on the deal, while Davis Polk advised the joint book-running managers and representatives of the several underwriters. Clinical stage...
You must be a Standard 1 Year member to access this content.
Simpson Thacher represented the underwriters in the offering. Nuvalent, Inc. (“Nuvalent”) executed its registered follow-on offering of 7,895,522 shares of Class A common stock. The offering...
You must be a Standard 1 Year member to access this content.
Covington represented the placement agents on the deal. Immunic, Inc. (Nasdaq: IMUX) (“Immunic” or the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of selective oral...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Homburger advised VectivBio. VectivBio Holding AG (Nasdaq: VECT) has announced the pricing of an underwritten offering of 16,700,000...
You must be a Standard 1 Year member to access this content.
